Tolerance to SARS-CoV-2 mRNA Vaccination in a Patient With Challenge-Confirmed PEG 2000 Allergy

Faihs, V; Bent, R; Darsow, U; Biedermann, T; Brockow, K

Faihs, V; Bent, R; Darsow, U; Biedermann, T; Brockow, K.

Affiliation

Faihs, V; Technical University of Munich. School of Medicine. Department of Dermatology and Allergy Biederstein. Munich. Germany
Bent, R; Technical University of Munich. School of Medicine. Department of Dermatology and Allergy Biederstein. Munich. Germany
Darsow, U; Technical University of Munich. School of Medicine. Department of Dermatology and Allergy Biederstein. Munich. Germany
Biedermann, T; Technical University of Munich. School of Medicine. Department of Dermatology and Allergy Biederstein. Munich. Germany
Brockow, K; Technical University of Munich. School of Medicine. Department of Dermatology and Allergy Biederstein. Munich. Germany

J. investig. allergol. clin. immunol ; 33(2): 149-150, 2023. tab

Article in English | IBECS | ID: ibc-219425

Responsible library: ES1.1

Localization: ES15.1 - BNCS

Subject(s)

Humans; Female; Aged; Coronavirus Infections/prevention & control; Viral Vaccines/administration & dosage; Polyethylene Glycols/adverse effects; Drug Hypersensitivity; RNA, Messenger

SARS-CoV-2; COVID-19; Polyethylene glycol; mRNA vaccine; Anaphylaxis; SARS-CoV-2; COVID-19; Polietilenglicol; Vacuna mRNA; Anafilaxia

Fulltext

Add to My VHL

XML

Search on Google

Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Polyethylene Glycols / Viral Vaccines / Coronavirus Infections / Drug Hypersensitivity Limits: Aged / Female / Humans Language: English Journal: J. investig. allergol. clin. immunol Year: 2023 Document type: Article Institution/Affiliation country: Technical University of Munich/Germany

Fulltext

Add to My VHL

XML

Search on Google